Intrepid USA: Who Got Admitted, Who Stayed, and Who Saw It

In the Intrepid USA hospice settlement, the company agreed to pay $3,850,000 to resolve Medicare billing allegations involving ineligible hospice patients and separate home-health conduct. The amount reflected Intrepid’s ability to pay, putting the company’s finances at the center of the resolution.

The Department of Justice announced the settlement on August 20, 2024. The Dallas-based provider’s hospice fraud case concerned allegations that patients were admitted without the required terminal prognosis and kept in care when they should have been discharged. For an insider, that second allegation matters as much as the first. The question follows the patient beyond intake, into the later decisions that keep Medicare paying.

What Intrepid’s Settlement Covered

The hospice allegations covered three facilities during periods from 2016 through 2021. The government alleged that they admitted ineligible patients or continued providing hospice services to patients who should have been discharged. That is the alleged hospice eligibility fraud at the center of this case: whether the patient’s condition supported admission and continued enrollment.

The companion home-health case concerned 19 facilities. The agreement’s home-health allegations addressed therapy and how long patients received services.

The hospice facilities were in Roseville, Minnesota, Springfield, Missouri, and North Charleston, South Carolina.

What Makes Someone Ineligible for Hospice?

A patient who lacks the required terminal prognosis does not meet Medicare’s clinical eligibility standard for hospice. That standard is a life expectancy of six months or less if the illness runs its normal course, as Medicare’s hospice coverage manual explains. Intrepid’s hospice allegations concerned both admitting patients without that prognosis and retaining patients who no longer qualified.

For someone who knows the patient, the important connection is between what the clinical information shows and the prognosis used to keep the benefit in place.

How Often Do Hospice Patients Need to Be Recertified?

Hospice patients need a written certification for every benefit period. Medicare allows two periods of up to 90 days, followed by renewable periods of up to 60 days. Before the third benefit period and every later recertification, Medicare also requires a hospice physician or nurse practitioner to conduct a face-to-face encounter to gather current clinical information.

That creates repeated decisions about the same patient. A clinical concern raised after admission belongs in the account of the later recertification and continued billing. The original intake paperwork tells only the beginning of that story.

What Happens If a Hospice Patient Lives Longer Than Six Months?

A patient can continue receiving hospice care when the required recertifications support continued eligibility. The clinical question remains whether the illness supports the terminal prognosis at that point. Intrepid’s alleged retention problem concerned continued care for people who should have been discharged.

Why Keeping a Patient Keeps the Payment

Medicare pays hospice for each enrolled day, including days without a staff visit. MedPAC’s March 2026 report describes that payment structure. Care costs tend to be highest around admission and near death, with a less expensive stretch between them. An enrollment decision therefore has a continuing financial value to the provider.

The connection to hospice billing is direct. Keeping an ineligible patient enrolled can keep daily claims moving through the system. The patient assessment, the certification and the decision about discharge each help explain why those claims continued.

A 2026 Kansas State University working paper, Quality, Reputation, and Reimbursement Design in the Hospice Industry, modeled competition among California hospices and used visit frequency as its measure of quality. It found that paying partly for visits could maintain the model’s quality level at lower Medicare spending.

In Intrepid’s case, the government’s eligibility allegations put the admission and discharge decisions at the center of that payment relationship. The government alleged that Intrepid billed Medicare for patients who did not meet the benefit’s clinical requirements. Taxpayers bore the cost of the alleged improper billing.

What the Insider Roles Reveal

The Intrepid cases began with four former health care employees in two distinct groups. The hospice case came from the travel nurse and the director of quality assessment, performance improvement and new business development. The home-health case came from a director of clinical excellence and integrity and a regional manager of clinical excellence.

With healthcare whistleblowers, we look at how a bedside observation compares with the certification packet, whether a discharge recommendation reached management, and what the billing shows after an internal review. That connects the patient, the company’s decision and the claim Medicare received.

An employee who knows why a recommendation was rejected can explain something the final chart may never say. An employee who reviewed charts across locations may recognize a repeated instruction. We work with that knowledge to identify the practice behind the individual claim.

Separate Awards for Separate Cases

The settlement resolved two qui tam cases, the hospice case in Minnesota and the home-health case in Kentucky. Its award provisions likewise distinguish the groups: one award for the hospice pair and another for the home-health pair, payable from the government’s recovery.

A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.

When a Discharge Decision Becomes a Business Decision

The Evercare Hospice case shows how a concern about enrollment can appear inside a patient’s record. Evercare agreed to an $18 million settlement in 2016, larger than Intrepid’s ability-to-pay resolution. The allegations involved patients whose records did not support terminal illness and practices that discouraged appropriate discharge. In its complaint, the government quoted an alleged management instruction:

The stated reason in that instruction was the number of patients on the rolls. It gives concrete form to a business decision that a nurse or quality employee might be asked to carry out. Intrepid’s separate allegations also reached continued enrollment. For an insider, knowing who wanted a patient kept in care, and why, can explain the decision behind the Medicare bill.

You Saw the Patient and the Decision

If your nursing or quality work exposed a gap between a patient’s condition and the decision to keep billing, speak to our whistleblower experts about what happened. We build your strongest hospice whistleblower case with you around the clinical evidence and the company’s decisions, bring in hospice fraud whistleblower lawyers who understand eligibility and billing cases, and stay beside you throughout.